Juan-Jose Guijarro-Leach

Head Of Analytical Development at Xap Therapeutics

Juan-Jose Guijarro-Leach currently serves as the Head of Analytical Development at Xap Therapeutics, a position held since January 2024. Prior to this role, Juan-Jose was the Head of Analytical Development and Principal Scientist in the same field at GammaDelta Therapeutics from September 2020 to December 2023. Juan-Jose's earlier experience includes serving as a Senior Analytical Development Scientist at Cell and Gene Therapy Catapult from January 2014 to September 2020, following a position as an Analytical Development Scientist. The academic background includes a PhD in Regenerative Medicine from Loughborough University, where the doctoral research focused on the characterisation of human embryonic stem cell processing methods. Prior educational achievements include a Master’s degree in Biochemical Engineering from University College London.

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices


Xap Therapeutics

1 followers

Xap Therapeutics is a start-up biotechnology company that is developing an innovative, synthetic biology-driven platform for cell therapeutics.Xap Therapeutics, formed by biotech entrepreneurs, is a producer of a "chassis" cell which functions in cell therapies through genetically engineered constructs. Xap Therapeutics wasestablished in 2017 by James Patterson, M.D., Ph.D in Cambridge, England.


Employees

11-50

Links